Implementations by Phenotype

Title Phenotypesort descending Institution Algorithm Type Total Cases Total Controls PPV Sensitivity
Harvard CDiff Clostridium Difficile Colitis Harvard Medical School Case Only 47 1,643
CHOP eM3 Clostridium Difficile Colitis CHOP Case, Control 104 214
NU C. diff. e3 new cases/ctls Clostridium Difficile Colitis Northwestern University Case, Control 75 348
Demonstration Project T2D Implementation Type 2 Diabetes - Demonstration Project Vanderbilt University Case, Control 100%, 100%
Demonstration Project RA Implementation Rheumatoid Arthritis - Demonstration Project Vanderbilt University Case, Control 97%, 100%
Demonstration Project MS Implementation Multiple Sclerosis - Demonstration Project Vanderbilt University Case, Control 87%, 100%
Demonstration Project Crohn's Disease Implementation Crohn's Disease - Demonstration Project Vanderbilt University Case, Control 100%, 100%
Demonstration Project AF Implementation Atrial Fibrillation - Demonstration Project Vanderbilt University Case, Control 98%, 100%
Clopidogrel Poor Metabolizers-Columbia Clopidogrel Poor Metabolizers Columbia University Case Only
VUMC ACEi cough implementation ACE Inhibitor (ACE-I) induced cough Vanderbilt University Case, Control 100%, 100% 96%
Validation of ACEi-induced cough algorithm ACE Inhibitor (ACE-I) induced cough Mayo Clinic Case, Control 100%, 96%
NU ACE Inhibitor (ACE-I) induced cough implementation ACE Inhibitor (ACE-I) induced cough Northwestern University The Feinberg School of Medicine Case, Control 100%, 98%
Marshfield ACE-I cough implentation ACE Inhibitor (ACE-I) induced cough Marshfield Clinic Research Foundation Case, Control 25 25 100%, 96%
Network Combined Dataset - ACE-I induced Cough ACE Inhibitor (ACE-I) induced cough Case, Control
ACEi Cough Implementation - Columbia ACE Inhibitor (ACE-I) induced cough Columbia University Case, Control 17 233
Diverticulosis Implementation - Columbia Diverticulosis and Diverticulitis Columbia University Case, Control 66 689
Geisinger eMERGE3 Combined Implementation Diverticulosis and Diverticulitis Geisinger Case, Control 97%, 94%
Harvard Implementation Diverticulosis and Diverticulitis Harvard Medical School Case, Control 884 770
VU E3 implementation Diverticulosis and Diverticulitis Vanderbilt University Medical Center Case, Control
Mayo Clinic eMERGE III Implementation Diverticulosis and Diverticulitis Mayo Clinic Case, Control 3,679 2,459
GHUW Diverticulitis Diverticulosis and Diverticulitis GHRI/UW Case, Control
NU e3 Diverticulosis Diverticulosis and Diverticulitis Northwestern University Case, Control 1,273 1,211
Diverticulosis May 2012 Implementation Diverticulosis and Diverticulitis Northwestern University The Feinberg School of Medicine Case, Control 98%, 89% 99%, 98%
Vanderbilt evaluation for Diverticulosis Diverticulosis and Diverticulitis Vanderbilt University Case Only 88%
Marshfield diverticulosis/diverticulitis implementation Diverticulosis and Diverticulitis Marshfield Clinic Research Foundation Case, Control 50 50 100%, 100%

Pages